On Tuesday morning, just over nine months after purchasing AstraZeneca’s 70-acre, six-building campus at 4000 Nelson Road in Longmont, AveXis reopened it as the biotech company’s new gene ...

After receiving FDA breakthrough therapy status for its lead candidate in July, gene therapy company AveXis has released promising new safety and efficacy data. AVXS-101 is being developed to ...

At AveXis, a Novartis company, we have built on 30 years of science to deliver on this challenge by demonstrating the long-term curative potential of gene therapy and its capacity to make an ...